Terumo Corp.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Capital-Expenditures" stands at 72.38 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2023.
Terumo Corp.'s second quarter result of 18.46 Billion JPY for the item "Capital Expenditures" represents an increase of 8.63 percent compared to it's first quarter result.
Also, Terumo Corp.'s second quarter result of 18.46 Billion JPY for the item "Capital Expenditures" represents an increase of 12.33 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Terumo Corp.'s second quarter result of 72.38 Billion JPY for the item "Capital Expenditures" represents an increase of 2.88 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.65 percent compared to the value the year prior.
The 1 year change in percent is 12.65.
The 3 year change in percent is 44.03.
The 5 year change in percent is 7.68.
The 10 year change in percent is 36.88.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Capital Expenditures | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Capital Expenditures | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Capital Expenditures | 172,241,486,586.05 |
![]() | Danaher Corporation - Capital Expenditures | 162,006,663,168.00 |
![]() | Boston Scientific Corp - Capital Expenditures | 144,567,730,176.00 |